SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
69 hedge funds and large institutions have $106M invested in Strongbridge Biopharma plc. in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
+9
Holders Change %
+15%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
15
Increased
25
Reduced
20
Closed
6
Calls
$98K
Puts
–
Net Calls
+$98K
Net Calls Change
+$92K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$4.22M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$1.35M |
| 3 |
Renaissance Technologies
New York
|
+$1.1M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$993K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$700K |
Top Sellers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$742K |
| 2 |
JPMorgan Chase & Co
New York
|
-$625K |
| 3 |
D.E. Shaw & Co
New York
|
-$580K |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$459K |
| 5 |
BlackRock
New York
|
-$435K |
